Skip to main content
Quest Diagnostics

Measures of Insulin Resistance (IR) Increase with Increasing BMI in a Population of Normoglycemic Working Adults

WCIRDC 2024

World Congress Insulin Resistance & Cardiovascular Disease

Universal City, CA,  Dec 12-14, 2024

Poster presentation: Measures of Insulin Resistance (IR) Increase with Increasing BMI in a Population of Normoglycemic Working Adults

Authors: Louie J, Shiffman D, Meigs J, Bare L, McPhaul MJ

Specialty: Cardiology, Endocrinology

Related content

Audio Podcast
Action From Insight: Tackling Insulin Resistance
Publication
Insulin Resistance Probability Score and Incident Cardiovascular Disease
Test FAQ
Insulin Intact LC MS MS
Conference Presentation
Insulin resistance probability score and cardiovascular events in the elderly
Conference Presentation
The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.